Acknowledgement to Referees Acknowledgement to Referees Open access 08 November 2023 Pages: 297 - 299
Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature Aparna Wagle ShuklaCaroline LunnyAshutosh M. Shukla Review Article Open access 22 August 2023 Pages: 301 - 329
The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis Martin VališAnat AchironZbyšek Pavelek Review Article Open access 28 August 2023 Pages: 331 - 338
A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder James C. MillerMichael A. BrooksJohn F. Wurzel III Review Article Open access 08 November 2023 Pages: 339 - 362
In-Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period Minji TakHawon JeongSu Jin Park Original Research Article Open access 22 August 2023 Pages: 363 - 375
Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab Yijia JiangTaruna AroraKaren J. Miller Original Research Article Open access 26 August 2023 Pages: 377 - 395
Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways Massimo MapelliIrene MattavelliPiergiuseppe Agostoni Original Research Article Open access 13 September 2023 Pages: 397 - 402
Pharmacovigilance Study of Infigratinib: A Safety Analysis of the FDA Adverse Event Reporting System Dehua ZhaoXiaoqing LongJisheng Wang Original Research Article Open access 12 September 2023 Pages: 403 - 409
Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers Ariel R. Topletz-EricksonJoAl G. MayorChristopher J. Endres Original Research Article Open access 26 September 2023 Pages: 411 - 419
Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product Greg CantinQian LiuJennifer Liu Original Research Article Open access 13 October 2023 Pages: 421 - 438
Simvastatin Preferentially Targets FLT3/ITD Acute Myeloid Leukemia by Inhibiting MEK/ERK and p38-MAPK Signaling Pathways Genhong LiJingwei YaoBing Xu Original Research Article Open access 17 October 2023 Pages: 439 - 451
Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor Agonist Handan HeJinzi J. Wu Original Research Article Open access 02 November 2023 Pages: 453 - 464
Effect of High-Fat Food on the Pharmacokinetic Profile and Safety of SAF-189s, an ALK/ROS1 Inhibitor, in Healthy Chinese Adults Huiling QinYan TanWei Hu Original Research Article Open access 07 November 2023 Pages: 465 - 473